StockNews.AI
ILMN
StockNews.AI
222 days

Illumina to Announce Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 6, 2025

1. Illumina to announce Q4 2024 results on February 6, 2025. 2. CEO Jacob Thaysen will lead the conference call for results discussion. 3. Conference call accessible via Illumina's website for stakeholders. 4. Illumina focuses on genomic innovation in various markets, enhancing health.

Earnings
-2.14%Current Return
VS
-1.53%S&P 500
$139.6801/09 04:24 PM EDTEvent Start
$136.6901/10 10:51 PM EDTLatest Updated
4m saved
Insight
Article

FAQ

Why Neutral?

Earnings announcements typically have mixed effects depending on results. Historical trends show volatility post-earning calls.

How important is it?

Earnings announcements are significant but depend on actual results for impact.

Why Short Term?

Immediate reactions expected post-announcement, but long-term depending on results.

Related Companies

ILMN
, /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) announced today that it will issue results for the fourth quarter and full year 2024 following the close of market on Thursday, February 6, 2025.  On the same day, at 1:30 pm Pacific Time (4:30 pm Eastern Time) Jacob Thaysen, PhD, Chief Executive Officer, and Ankur Dhingra, Chief Financial Officer, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results.  Conference Call Details The conference call will begin at 1:30 pm Pacific Time (4:30 pm Eastern Time) on Thursday, February 6, 2025. Interested parties may access the live webcast via the Investor Info section of Illumina's website or directly through the following link - https://illumina-earnings-call-q4-2024.open-exchange.net/. To ensure timely connection, please join at least ten minutes before the scheduled start of the call. A replay of the conference call will be posted on Illumina's website after the event and will be available for at least 30 days following. About Illumina Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com and connect with us on X (Twitter), Facebook, LinkedIn, Instagram, TikTok, and YouTube Investors:Salli Schwartz+1.858.291.6421[email protected] Media:Bonny Fowler+1.740.641.5579[email protected] SOURCE Illumina, Inc. WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News